Gail L. Rosseau, M.D.

Gail L. Rosseau, M.D.

Gail L. Rosseau, M.D.

Log into NorthShoreConnect

Profile

Personal Bio

Treatment Philosophy

My philosophy has always been fairly simple to describe: high tech and high touch. By high tech I mean that I strive to provide every patient with state of the art knowledge, technique and tools that will improve or cure their condition. By high touch, I mean that I will provide compassionate care, listening to, and trying to respond to all their needs. In short, my goal is to provide for every patient and their family the kind of care that I would want to have for my family.

Personal Interests

I like French language and culture, running marathons, history and learning about wines.

Conditions & Procedures

Conditions

astrocytoma, Atypical Facial Pain, Back Pain, Brain Bleed, Brain Tumor, Cerebrospinal Fluid (CSF) Leak, Cervical/Lumbar Disc Disease, Chiari Malformation, Chordoma, Concussion, Cranial Base Tumors, Craniopharyngioma, Ependynoma, Glioblastoma, Glioma, Hemifacial Spasm, Hydrocephalus, Idiopathic Intracranial Hypertension, Meningioma, Neoplasm, Normal Pressure Hydrocephalus, Pineal Cyst, Pituitary Adenoma (Micro or Macro- Adenoma), Pituitary Tumor, Pseudo Tumor Cerebri, Rathke's Cleft Cyst, Subarachnoid Hemorrhage (SAH), Subdural Hematoma (SDH), Syringomyelia, Trigeminal Neuralgia, Vestibular Schwanoma

Procedures

Stereotactic Neurosurgery and Radiosurgery (SRS), Stereotactic Radiosurgery of Spine

General Information

Gender

Female

Affiliation

NorthShore Medical Group

Academic Rank

Clinical Assistant Professor

Languages

English, French

Board Certified

Neurological Surgery

Clinical Service

Neurosurgery

Education, Training & Fellowships

Medical School

George Washington University Medical School, 1985

Internship

George Washington University Medical Center, 1986

Residency

George Washington University Medical Center, 1991

Fellowship

University of Pittsburgh, 1992

Locations

A

NorthShore Medical Group

2180 Pfingsten Rd.
Suite 2000
Glenview, IL 60026
847.570.1440 847.570.1442 fax This location is wheelchair accessible.
B

NorthShore Medical Group

9650 Gross Point Rd.
Suite 3900
Skokie, IL 60076
847.570.1440 847.570.1442 fax This location is wheelchair accessible.

Insurance

Every effort has been made to ensure the accuracy of the information in this directory. However, some changes may occur between updates. Please check with your provider to ensure that he or she participates in your health plan.

Aetna HMO/PPO/POS
BCBS HMOI
BCBS PPO *except Blue Choice IL
Beechstreet PPO
CCN PPO
CIGNA Choice Fund
CIGNA Choice Fund PPO
CIGNA EPO
CIGNA Network
CIGNA Network Open Access
CIGNA POS
CIGNA POS Open Access
CIGNA PPO
CIGNA:Open Access Plus
First Health PPO
Galaxy PPO
Great West POS
Great West PPO
Healthcares Finest Network PPO
Humana Choice Care PPO
Humana IPA--HMO
Humana POS
Humana PPO
Land of Lincoln
Medicare
Multiplan Admar PPO
Multiplan Formost PPO
Multiplan Health Network PPO
Multiplan Wellmark PPO
NorthShore Employee Network I (EPO Option)
NorthShore Employee Network II (EPO Plus & CDHP)
PHCS PPO
Preferred Plan PPO
Railroad Medicare - Cook County
Railroad Medicare - Lake County
UHC *except Core & Navigate
Unicare PPO

Publications

  • The development of a virtual simulator for training neurosurgeons to perform and perfect endoscopic endonasal transsphenoidal surgery.

    Neurosurgery 2013 Oct

    Authors: Rosseau G,
    Abstract
    A virtual reality (VR) neurosurgical simulator with haptic feedback may provide the best model for training and perfecting surgical techniques for transsphenoidal approaches to the sella turcica and cranial base. Currently there are 2 commercially available simulators: NeuroTouch (Cranio and Endo) developed by the National Research Council of Canada in collaboration with surgeons at teaching hospitals in Canada, and the Immersive Touch. Work in progress on other simulators at additional institutions is currently unpublished.
    This article describes a newly developed application of the NeuroTouch simulator that facilitates the performance and assessment of technical skills for endoscopic endonasal transsphenoidal surgical procedures as well as plans for collecting metrics during its early use.
    The main components of the NeuroTouch-Endo VR neurosurgical simulator are a stereovision system, bimanual haptic tool manipulators, and high-end computers. The software engine continues to evolve, allowing additional surgical tasks to be performed in the VR environment. Device utility for efficient practice and performance metrics continue to be developed by its originators in collaboration with neurosurgeons at several teaching hospitals in the United States. Training tasks are being developed for teaching 1- and 2-nostril endonasal transsphenoidal approaches. Practice sessions benefit from anatomic labeling of normal structures along the surgical approach and inclusion (for avoidance) of critical structures, such as the internal carotid arteries and optic nerves.
    The simulation software for NeuroTouch-Endo VR simulation of transsphenoidal surgery provides an opportunity for beta testing, validation, and evaluation of performance metrics for use in neurosurgical residency training.
    CTA, cognitive task analysisVR, virtual reality.
    PMID: 24051889 [PubMed - as supplied by publisher]
  • Prospective validation of a patient-reported nasal quality-of-life tool for endonasal skull base surgery: The Anterior Skull Base Nasal Inventory-12.

    Journal of neurosurgery 2013 Oct

    Authors: Little AS,
    Abstract
    Patient-reported quality-of-life (QOL) end points are becoming increasingly important health care metrics. To date, no nasal morbidity instrument specifically designed for patients undergoing endonasal skull base surgery has been developed. In this study, the authors describe the development and validation of a site-specific nasal morbidity instrument to assess patient-reported rhinological outcomes following endonasal skull base surgery.
    Eligible patients included those with planned endonasal transsphenoidal surgery for sellar pathology identified in outpatient neurosurgical clinics of 3 skull base centers from October 2011 to July 2012. An initial 23-question pool was developed by subject matter experts, review of the literature, and from the results of a previous validation study to assess for common rhinological complaints. Symptoms were ranked by patients from "No Problem" to "Severe Problem" on a 6-point Likert scale. Exploratory factor analysis, change scores, and importance rank were calculated to define the final instrument consisting of 12 items (The Anterior Skull Base Nasal Inventory-12, or ASK Nasal-12). Psychometric validation of the final instrument was performed using standard statistical techniques.
    One hundred four patients enrolled in the study. All patients completed the preoperative survey and 100 patients (96%) completed the survey 2-4 weeks after surgery. Internal consistency of the final instrument was 0.88. Concurrent validity measures demonstrated a strong correlation between overall nasal functioning and total scores (p < 0.001). Test-retest reliability measures demonstrated a significant intraclass correlation between responses (p < 0.001). Effect size as calculated by standardized response mean suggested a large effect (0.84). Discriminant validity calculations demonstrated that the instrument was able to discriminate between preoperative and postoperative patients (p < 0.001).
    This prospective study demonstrates that the ASK Nasal-12 is a validated, site-specific, unidimensional rhinological outcomes tool sensitive to clinical change. It can be used in conjunction with multidimensional QOL instruments to assess patient-reported nasal perceptions in endonasal skull base surgery. This instrument is being used as a primary outcome measure in an ongoing multicenter nasal morbidity study. Clinical trial registration no.: NCT01504399 (ClinicalTrials.gov).
    PMID: 23662829 [PubMed - as supplied by publisher]
  • The evolution of image guidance in transsphenoidal pituitary surgery.

    World neurosurgery 2013 Feb

    Authors: Kano H,
    Abstract
    Although considered slow-growing, low-grade malignancies, chordomas are locally aggressive and destructive tumors with high recurrence rates.
    To assess patient survival, tumor control, complications, and selected variables that predict outcome in patients who underwent Gamma Knife stereotactic radiosurgery (SRS) as primary, adjuvant, or salvage management for chordomas of the skull base.
    Six participating centers of the North American Gamma Knife Consortium identified 71 patients who underwent SRS for chordoma. The median patient age was 45 years (range, 7-80 years). The median SRS target volume was 7.1 cm³ (range, 0.9-109 cm³), and median margin dose was 15.0 Gy (range, 9-25 Gy).
    At a median follow-up of 5 years (range, 0.6-14 years) after SRS, 23 patients died of tumor progression. The 5-year actuarial overall survival after SRS was 80% for the entire group, 93% for the no prior fractionated radiation therapy (RT) group (n = 50), and 43% for the prior RT group (n = 21). Younger age, longer interval between initial diagnosis and SRS, no prior RT, < 2 cranial nerve deficits, and smaller total tumor volume were significantly associated with longer patient survival. The 5-year treated tumor control rate after SRS was 66% for the entire group, 69% for the no prior RT group, and 62% for the prior RT group. Older age, recurrent group, prior RT, and larger tumor volume were significantly associated with worse tumor control.
    Stereotactic radiosurgery is a potent treatment option for small sized chordomas, especially in younger patients and as part of a multipronged attack that includes surgical resection when possible.
    PMID: 23270710 [PubMed - as supplied by publisher]

In the News

Mar 2014

Nov 2013

Featured Videos

Dr. Gail Rosseau discusses facial pain and the causes of trigeminal neuralgia.

Dr. Gail Rosseau discusses facial pain and the causes of trigeminal neuralgia.

Dr. Gail Rosseau discusses Chiari Malformation in her weekly video blog.

Dr. Gail Rosseau discusses Chiari Malformation in her weekly video blog.

× Alternate Text